id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_nwilyqphvzc7rgd5cko3vcggc4	A Hartmann	Occlusive Treatment Enhances Efficacy of Tacrolimus 0.1% Ointment in Adult Patients with Vitiligo: Results of a Placebo-controlled 12-month Prospective Study	2008.0	6	.pdf	application/pdf	4668	393	64	vitiligo patients with tacrolimus 0.1% ointment twice After 12 months, 17 of 21 patients (81%) with facial involvement showed repigmentation of the face. long-term treatment with topical tacrolimus is effective and safe in patients with long disease duration and Ointment in Adult Patients with Vitiligo: Results of a Placebocontrolled 12-month Prospective Study (with and without occlusion) and on the feet no treatment response was seen in any of the patients. In 16 of 17 patients (94%) who used additional occlusive dressings on the arms, repigmentation could be mean DLQI score for patients with no or poor treatment a study on 110 patients, combined treatment of tacrolimus and narrow-band UVB led to good to excellent (B) After 12 months of treatment with 0.1% tacrolimus ointment occlusion therapy can enhance the effect of topical tacrolimus therapy in vitiligo. In our study, all patients had tacrolimus laser and topical tacrolimus for the treatment of vitiligo: a 	./cache/work_nwilyqphvzc7rgd5cko3vcggc4.pdf	./txt/work_nwilyqphvzc7rgd5cko3vcggc4.txt